Drug Search Results
More Filters [+]

Sodium fluoride f-18

Alternative Names: sodium fluoride f-18, sodium fluoride f 18, fluorine f-18
Latest Update: 2024-03-06
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Radioactive Agent

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Atom Technology Co., Ltd.
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Sodium fluoride f-18

Countries in Clinic: China

Active Clinical Trial Count: 3

Highest Development Phases

Phase 3: Bone Marrow Diseases|Oncology Unspecified

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

BJK-Z-F18HN-202010-YZGK

P3

Completed

Bone Marrow Diseases

2022-06-02

CTR20201663

P3

Recruiting

Oncology Unspecified

None

CTR20210217

P3

Not yet recruiting

Oncology Unspecified

None

Recent News Events

Date

Type

Title